What does CUSIP 30049G104 represent in this 13F holders report?

CUSIP 30049G104 is the security identifier for EVOK - EVOKE PHARMA INC - COM used to aggregate holder disclosures.

How many institutions held EVOK - EVOKE PHARMA INC - COM in Q1 2014?

10 institutional investors reported EVOK - EVOKE PHARMA INC - COM for Q1 2014. Use the holders table for investor-level position and value details.

EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class: Equity / COM
Total 13F shares: 411,914
Share change: +272,103
Total reported value: $3,447,000
Price per share: $8.33
Number of holders: 10
Value change: +$2,296,444
Number of buys: 6
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2014
Previous quarter: Q4 2013

Recent filing periods for CUSIP 30049G104:

Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020 Q3 2020

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q1 2014

As of 31 Mar 2014, EVOKE PHARMA INC - COM (EVOK) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 411,914 shares. The largest 10 holders included Opaleye Management Inc., SOPHROSYNE CAPITAL LLC, VANGUARD GROUP INC, BANK OF AMERICA CORP /DE/, LMR Partners LLP, TFS CAPITAL LLC, GEODE CAPITAL MANAGEMENT, LLC, CITIGROUP INC, UBS AG, and MORGAN STANLEY. This page lists 10 institutional shareholders reporting positions in this security for the Q1 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.